Nafarelin CAS: 76932-56-4 RS-94991-298 Nasanyl

Nafarelin, inotengeswa pasi pemazita ekutengeserana akadai saSynarel, igonadotropin inoburitsa mahormone agonist (GnRH agonist) mushonga unoshandiswa kurapa endometriosis uye kusati kwatanga kuyaruka.Inoshandiswawo kurapa uterine fibroids, kudzora ovarian kukurudzira panguva in vitro fertilization (IVF), uye sechikamu chemuchinjikwa-sex hormone therapy.Mushonga unoshandiswa semushonga wemhino kaviri kana katatu pazuva.

Zvimwe zvinokonzerwa ne nafarelin zvinosanganiswa nekushayikwa kwehomoni yepabonde uye zvinosanganisira zviratidzo zvemazinga e testosterone akaderera uye mazinga eesrogen akaderera, zvakadai sekupisa kunopisa, kusagadzikana kwepabonde, vaginal atrophy, uye osteoporosis.Nafarelin inonzi gonadotropin-releasing hormone agonist (GnRH agonist) inoshanda nekudzivirira magonads kuburitsa mahormone ebonde.Inogona kuderedza mazinga ehomoni dzepabonde muvarume vose ne95 muzana.Nafarelin ipeptide iri analogue yeGnRH.

Nafarelin yakaunzwa kuti ishandiswe mukurapa muna 1990. Inoshandiswa zvakanyanya pasi rose, kusanganisira North America, Europe, nedzimwe nzvimbo dzepasi.Mushonga uyu ndeumwe wemaanalogue maviri eGnRH anoshandiswa mukurapa anowanikwa semushonga wemhino, imwe yacho iri Bucherelin.

Kushandiswa kwekurapa:
Nafarelin inotenderwa kurapa endometriosis uye kuyaruka kusati kwasvika.Inoshandiswawo kurapa uterine fibroids.Mushonga unoshandiswa kudzora kukurudzirwa kwe ovarian panguva ye in vitro fertilization (IVF).Nafarelin inoshandiswa sevhavha yekuyaruka kune transgender vechidiki uye kudzvanya mazinga e testosterone muvakadzi ve transgender.Nafarelin inogonawo kushandiswa kurapa hypertrichosis uye polycystic ovary syndrome nekuderedza gonadotropin uye androgen mazinga.Inoshanda mukurapa benign prostatic hyperplasia